The chick embryo chorioallantoic membrane patient-derived xenograft (PDX) model

Domenico Ribatti1

  • 1Department of Translational Biomedicine and Neuroscience, University of Bari Medical School, Bari, Italy.

Insights

The chick embryo chorioallantoic membrane (CAM) is a versatile model for studying tumor growth and drug efficacy. Its immunodeficient nature and ethical advantages facilitate research on patient-derived xenografts (PDX).

Area of Science:

  • Developmental Biology
  • Oncology
  • Pharmacology

Background:

  • The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane crucial for embryonic development.
  • It supports vital functions like respiration, ion transport, and homeostasis.
  • The CAM model is widely adopted for studying angiogenesis, tumor biology, and drug responses.

Purpose of the Study:

  • To review the literature and present data on patient-derived xenografts (PDX) effects on the CAM.
  • To highlight the CAM's utility as a model for preclinical cancer research.

Main Methods:

  • Literature analysis and review of personal data.
  • Utilizing the chick embryo chorioallantoic membrane (CAM) as an in vivo model.
  • Transplantation of patient-derived xenografts (PDX) onto the CAM.

Main Results:

  • The CAM model allows for the study of tumor growth and metastasis in an immunodeficient environment.
  • Ethical considerations are simplified for experiments before embryonic day 14, supporting the 3Rs principle.
  • The CAM's acceptance of xenografts enables the evaluation of patient-specific tumor responses.

Conclusions:

  • The CAM is a valuable and reproducible model for investigating patient-derived xenografts (PDX).
  • Its unique properties facilitate large-scale screenings of therapies, aligning with ethical research principles.
  • Further research using the CAM model can advance personalized cancer treatment strategies.

Related Concept Videos